Israeli company DeepDense, which specializes in AI medical imaging, has teamed up with US firm Spectrum Dynamics Medical, a leading innovator in digital imaging, to develop innovative applications for analysis of cardiac and spine diseases.

By working together, the two companies aim to use DeepDense’s advanced AI technology to improve diagnostic accuracy, streamline workflows, and improve patient care.

The DeepDense AI applications will be added to Spectrum Dynamics’ portfolio of solutions, along with the former’s unique 3D labeling tools.

“The integration state of the art digital SPECT technology with advanced AI features will open the path to new capabilities in both imaging and treatment,” said Spectrum Dynamics CEO Gilad Yoeli.

“This partnership with DeepDense will enable Spectrum Dynamics to enhance our VERITON-CT® SPECT/CT and D-SPECT® platforms with customized AI capabilities to enable automatic quantitative analysis, improve image quality and reduce scan times. This agreement demonstrates our resolve to continue to be in the forefront of molecular imaging technology,” he said.

“Our collaboration has allowed us to uncover new opportunities for translating AI technology into enhanced patient care,” said DeepDense founder and CTO Yechiel Lamash.

Keep reading at nocamels.com.

DeepDense Medical Founder and CTO Yechiel Lamash is a Technion alumnus.